These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 23289518)

  • 1. Iron homeostasis in the metabolic syndrome.
    Datz C; Felder TK; Niederseer D; Aigner E
    Eur J Clin Invest; 2013 Feb; 43(2):215-24. PubMed ID: 23289518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Obesity as an emerging risk factor for iron deficiency.
    Aigner E; Feldman A; Datz C
    Nutrients; 2014 Sep; 6(9):3587-600. PubMed ID: 25215659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Iron overload and non-alcoholic fatty liver disease.
    Datz C; Müller E; Aigner E
    Minerva Endocrinol; 2017 Jun; 42(2):173-183. PubMed ID: 27834478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-fat, high-fructose diet induces hepatic iron overload via a hepcidin-independent mechanism prior to the onset of liver steatosis and insulin resistance in mice.
    Tsuchiya H; Ebata Y; Sakabe T; Hama S; Kogure K; Shiota G
    Metabolism; 2013 Jan; 62(1):62-9. PubMed ID: 22854109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dysmetabolic Hyperferritinemia and Dysmetabolic Iron Overload Syndrome (DIOS): Two Related Conditions or Different Entities?
    Rametta R; Fracanzani AL; Fargion S; Dongiovanni P
    Curr Pharm Des; 2020; 26(10):1025-1035. PubMed ID: 32003680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The molecular basis of iron overload disorders and iron-linked anemias.
    Kaplan J; Ward DM; De Domenico I
    Int J Hematol; 2011 Jan; 93(1):14-20. PubMed ID: 21210258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular control of iron transport.
    Ganz T
    J Am Soc Nephrol; 2007 Feb; 18(2):394-400. PubMed ID: 17229910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepcidin--central regulator of iron metabolism.
    Atanasiu V; Manolescu B; Stoian I
    Eur J Haematol; 2007 Jan; 78(1):1-10. PubMed ID: 17042775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dysregulation of iron and copper homeostasis in nonalcoholic fatty liver.
    Aigner E; Weiss G; Datz C
    World J Hepatol; 2015 Feb; 7(2):177-88. PubMed ID: 25729473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of mutations in SLC40A1 that affect ferroportin function and phenotype of human ferroportin iron overload.
    Mayr R; Griffiths WJ; Hermann M; McFarlane I; Halsall DJ; Finkenstedt A; Douds A; Davies SE; Janecke AR; Vogel W; Cox TM; Zoller H
    Gastroenterology; 2011 Jun; 140(7):2056-63, 2063.e1. PubMed ID: 21396368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Iron in fatty liver and in the metabolic syndrome: a promising therapeutic target.
    Dongiovanni P; Fracanzani AL; Fargion S; Valenti L
    J Hepatol; 2011 Oct; 55(4):920-32. PubMed ID: 21718726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepcidin resistance in dysmetabolic iron overload.
    Rametta R; Dongiovanni P; Pelusi S; Francione P; Iuculano F; Borroni V; Fatta E; Castagna A; Girelli D; Fargion S; Valenti L
    Liver Int; 2016 Oct; 36(10):1540-8. PubMed ID: 26998752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Age-related changes in iron homeostasis in mouse ferroxidase mutants.
    Chen H; Attieh ZK; Gao H; Huang G; Su T; Ke W; Vulpe CD
    Biometals; 2009 Oct; 22(5):827-34. PubMed ID: 19330300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The effect of alcohol on the regulation of iron metabolism].
    Cylwik B; Chrostek L; Szmitkowski M
    Pol Merkur Lekarski; 2008 Sep; 25(147):273-5. PubMed ID: 19112848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New insights into the regulation of iron homeostasis.
    Deicher R; Hörl WH
    Eur J Clin Invest; 2006 May; 36(5):301-9. PubMed ID: 16634833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A compartmental model of iron regulation in the mouse.
    Lao BJ; Kamei DT
    J Theor Biol; 2006 Dec; 243(4):542-54. PubMed ID: 16935308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alterations in lipid, carbohydrate and iron metabolism in patients with non-alcoholic steatohepatitis (NASH) and metabolic syndrome.
    Zimmermann A; Zimmermann T; Schattenberg J; Pöttgen S; Lotz J; Rossmann H; Roeddiger R; Biesterfeld S; Geiss HC; Schuchmann M; Galle PR; Weber MM
    Eur J Intern Med; 2011 Jun; 22(3):305-10. PubMed ID: 21570653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liver hepcidin mRNA expression is inappropriately low in alcoholic patients compared with healthy controls.
    Costa-Matos L; Batista P; Monteiro N; Simões M; Egas C; Pereira J; Pinho H; Santos N; Ribeiro J; Cipriano MA; Henriques P; Girão F; Rodrigues A; Carvalho A
    Eur J Gastroenterol Hepatol; 2012 Oct; 24(10):1158-65. PubMed ID: 22732356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of the kidney in iron homeostasis: renal expression of Prohepcidin, Ferroportin, and DMT1 in anemic mice.
    Veuthey T; D'Anna MC; Roque ME
    Am J Physiol Renal Physiol; 2008 Oct; 295(4):F1213-21. PubMed ID: 18653481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-fat diet causes iron deficiency via hepcidin-independent reduction of duodenal iron absorption.
    Sonnweber T; Ress C; Nairz M; Theurl I; Schroll A; Murphy AT; Wroblewski V; Witcher DR; Moser P; Ebenbichler CF; Kaser S; Weiss G
    J Nutr Biochem; 2012 Dec; 23(12):1600-8. PubMed ID: 22444869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.